CATALYST PHARMACEU financial statements, including revenue, expenses, profit, and loss

The total revenue of CN2 for the last quarter is 93.09 M CHF, and it's 0.98% lower compared to the previous quarter. The net income of Q4 23 is 29.34 M CHF.